Windlas Biotech share news, announcements and annual reports
NSE: WINDLASBSE: 543329Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹888.70.
29 Oct: open ₹899.70, high ₹936.40, low ₹887.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,906 Cr1,237th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 28.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 3.28
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.68%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,08,215
Windlas Biotech share news and announcements
322 announcements, routine notices left out, newest first. Page 6 of 7.
Aug 2022
4 Aug · General updates
Jul 2022
26 Jul · Business
26 Jul · Analysts
14 Jul · Analysts
14 Jul · Analysts
Jun 2022
28 Jun · Analysts
May 2022
25 May · Related Party Transaction
24 May · Business
12 May · General updates
12 May · Business
12 May · Results
12 May · Business
6 May · Analysts
Apr 2022
14 Apr · Business
6 Apr · Analysts
5 Apr · Analysts
4 Apr · Analysts
Mar 2022
31 Mar · Analysts
30 Mar · Analysts
Feb 2022
16 Feb · Analysts
4 Feb · Analysts
2 Feb · Business
2 Feb · Business
2 Feb · Board meeting
2 Feb · Results
1 Feb · Analysts
Jan 2022
29 Jan · Analysts
25 Jan · Board meeting
11 Jan · Analysts
Dec 2021
21 Dec · Business
10 Dec · Analysts
10 Dec · Analysts
Nov 2021
28 Nov · Analysts
17 Nov · Analysts
17 Nov · Analysts